771999--3/17/2008--DOCUMENT_SECURITY_SYSTEMS_INC

related topics
{property, intellectual, protect}
{acquisition, growth, future}
{stock, price, share}
{product, market, service}
{debt, indebtedness, cash}
{provision, law, control}
{cost, operation, labor}
{product, candidate, development}
{competitive, industry, competition}
{personnel, key, retain}
{product, liability, claim}
{control, financial, internal}
We have a limited operating history with our business model, which limits the information available to you to evaluate our business. We have secured credit facilities that have large principal payments due in January 2010, and if we are unable to repay them with cash we may be forced to repay, in whole or in part, with each credit facility s applicable collateral, which would have a material adverse effect on our financial position. We have secured credit facilities that have large principal payments due in January 2010, and if we are unable to repay them with cash we may be forced to repay, in whole or in part, with each credit facility s applicable collateral, which would have a material adverse effect on our financial position. Due to our low cash balance and negative cash flow, we may have to further reduce our costs by curtailing future operations. Our ability to effect a financing transaction to fund our operations could adversely affect the value of your stock. Our limited cash resources may not be sufficient to fund continuing losses from operations and the expenses of the current patent validity and patent infringement litigations. If we lose our current litigation, we may lose certain of our technology rights, which may affect our business plan. If we lose our current infringement litigation we may be liable for significant legal costs of our counterparts. If we are unable to adequately protect our intellectual property, our competitive advantage may disappear. We may face intellectual property infringement or other claims against us, our customers or our intellectual property that could be costly to defend and result in our loss of significant rights. If our products and services do not achieve market acceptance, we may not achieve our revenue and net income goals in the time prescribed or at all. Certain of our recently developed products are not yet commercially accepted and there can be no assurance that those products will be accepted, which would adversely affect our financial results. The results of our research and development efforts are uncertain and there can be no assurance of the commercial success of our products. Changes in document security technology and standards could render our applications and services obsolete. The market in which we operate is highly competitive, and we may not be able to compete effectively, especially against established industry competitors with greater market presence and financial resources. Our growth strategy depends, in part, on our acquiring complementary businesses and assets and expanding our existing operations to include manufacturing capabilities, which we may be unable to do. If we fail to retain our key personnel and attract and retain additional qualified personnel, we might not be able to pursue our growth strategy. If we do not successfully expand our sales force, we may be unable to increase our revenues. Future growth in our business could make it difficult to manage our resources. We cannot predict our future capital needs and we may not be able to secure additional financing. Risks Related to Our Stock Provisions of our certificate of incorporation and agreements could delay or prevent a change in control of our company. We have a large number of authorized but unissued shares of common stock, which our management may issue without further stockholder approval, thereby causing dilution of your holdings of our common stock. The exercise of our outstanding options and warrants and vesting of restricted stock awards may depress our stock price. We do not intend to pay cash dividends.

Full 10-K form ▸

related documents
771999--3/29/2007--DOCUMENT_SECURITY_SYSTEMS_INC
1043961--4/2/2007--TRANSGENOMIC_INC
1043961--3/31/2006--TRANSGENOMIC_INC
1043961--3/28/2008--TRANSGENOMIC_INC
1174891--12/22/2008--UPSTREAM_BIOSCIENCES_INC.
1172136--6/16/2008--US_GEOTHERMAL_INC
1107216--3/12/2008--ORCHID_CELLMARK_INC
1172136--6/9/2010--US_GEOTHERMAL_INC
1123494--3/16/2006--HARVARD_BIOSCIENCE_INC
1001193--3/30/2007--TRANSMETA_CORP
1118037--3/31/2009--MATHSTAR_INC
1063254--3/4/2008--S1_CORP_/DE/
1115975--4/15/2008--SILVERGRAPH_INTERNATIONAL_INC
1145460--3/1/2007--INVERNESS_MEDICAL_INNOVATIONS_INC
912544--3/17/2008--HOLLYWOOD_MEDIA_CORP
929940--11/9/2009--ASPEN_TECHNOLOGY_INC_/DE/
1094139--3/31/2010--OURPETS_CO
897893--5/12/2008--PEERLESS_SYSTEMS_CORP
357108--1/31/2007--IRVINE_SENSORS_CORP/DE/
225211--4/15/2009--MOBICLEAR_INC.
1043961--3/30/2009--TRANSGENOMIC_INC
769520--2/27/2008--MIDDLEBY_CORP
832488--9/30/2008--Aftersoft_Group
883907--4/29/2009--CURRENT_TECHNOLOGY_CORP
924642--4/1/2010--DIGITAL_ANGEL_CORP
1069489--4/15/2009--WESCORP_ENERGY_INC
1063254--3/5/2009--S1_CORP_/DE/
912241--3/17/2008--PROGRESSIVE_GAMING_INTERNATIONAL_CORP
1107216--5/24/2006--ORCHID_CELLMARK_INC
1260037--3/27/2008--Energtek